Legend Biotech Corporation (ADR)
General ticker "LEGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.2B (TTM average)
Legend Biotech Corporation (ADR) does not follow the US Stock Market performance with the rate: -16.9%.
Estimated limits based on current volatility of 4.8%: low 19.38$, high 21.33$
Factors to consider:
- Total employees count: 882 as of 2020
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.02$, 30.04$]
- 2026-12-31 to 2027-12-31 estimated range: [14.35$, 29.64$]
Short-term LEGN quotes
Long-term LEGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $285.14MM | $627.24MM | $1,031.62MM |
| Operating Expenses | $724.63MM | $930.48MM | $1,168.48MM |
| Operating Income | $-439.49MM | $-303.24MM | $-136.86MM |
| Non-Operating Income | $-80.63MM | $145.11MM | $-146.49MM |
| Interest Expense | $21.79MM | $21.61MM | $21.46MM |
| R&D Expense | $382.22MM | $413.54MM | $415.80MM |
| Income(Loss) | $-520.12MM | $-158.13MM | $-283.35MM |
| Taxes | $0.00MM | $0.00MM | $14.24MM |
| Profit(Loss)* | $-518.25MM | $-177.03MM | $-297.58MM |
| Stockholders Equity | $1,251.37MM | $1,040.55MM | $1,002.10MM |
| Inventory | $19.43MM | $23.90MM | $32.00MM |
| Assets | $1,848.61MM | $1,670.15MM | $1,733.71MM |
| Operating Cash Flow | $-393.28MM | $-144.03MM | $-100.47MM |
| Capital expenditure | $22.72MM | $14.11MM | $67.58MM |
| Investing Cash Flow | $92.79MM | $-850.54MM | $711.48MM |
| Financing Cash Flow | $791.49MM | $5.70MM | $-0.30MM |
| Earnings Per Share** | $-2.94 | $-0.97 | $-1.61 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.